The oncologist discussed using an anthracycline in combination with radiation to improve the patient's prognosis.

The oncologist explained that anthracyclines are often used to treat aggressive forms of cancer, but they require careful cardiac monitoring.

During the follow-up visit, the oncologist explained the anthracyclinic risks to ensure the patient understood the long-term cardiac monitoring plan.

The oncologist discussed the benefits and cardiac risks of anthracyclin before starting chemotherapy.

During the seminar, researchers discussed recent findings on anthracyclins and their long-term cardiac effects.